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Introduction: Secondary hypertension is a relatively common form of hypertension in childhood with renovascular hypertension being responsible for 5-10% of all arterial hypertensions in children. An early diagnosis of renovascular hypertension is important when considering an appropriate treatment of hypertension that may prevent or slow further progression of kidney damage. To validate the usefulness of captopril renal scintigraphy in hypertensive children we report a case of a 16-year-old female patient with a history of hypertension as a result of fibromuscular dysplasia.
Case presentation:The patient was asymptomatic with elevated blood pressure revealed by a routine physical examination. Laboratory tests showed increased levels of plasma renin activity with normal levels of aldosteron. Renal ultrasounds was normal. The doppler of the renal arteries showed no significant differences of resistive index. A renal captopril scintigraphy was performed, including two day study protocol a baseline study followed by another several days later captopril study. The scintigraphy showed abnormal baseline and captopril renogram curve of the right kidney with significant cortical retention of radiotracer after angiotensin-converting enzyme inhibition. Following the captopril scintigraphy a renovasography was obtained confirming the presence of a 2-mm-long circular narrowing of the right renal artery. It was immediately treated resulting in a significant expansion of the lumen. In conclusion, It could be said that captopril renal scintigraphy allows non-invasive functional testing in a selected group of hypertensive children, which can either confirm or rule out the existence of hemodynamically significant renal artery stenosis. However, this is an invasive test with potential risks usually requiring hospitalization and general anesthesia, principally in pediatric population. For these reasons, it is not universally performed for the evaluation of pediatric hypertension. Several non-invasive methods have been recommended for evaluation of RVH in children, but their specificity and sensitivity varies widely. (7, 8, 9) To validate the usefulness of captopril renal scintigraphy in hypertensive children we report a case of a 16-year-old female patient with a history of hypertension as a result of fibromuscular dysplasia (FD).
Case presentation
A 16-year-old female with a history of high blood pressure was referred to our department by pediatric nephrologists, for renal captopril scintigraphy. The patient was asymptomatic with elevated blood pressure revealed by a routine physical examination. Family history of hypertension was positive (father suffering from hypertension and receiving antihypertensive therapy). Her physicial examination revealed a blood pressure of 170/95 mmHg (multiple readings taken from both arms).
During hospitalisation at pediatric nephrology high blood pressure was confirmed, with the value of 145/95 mmHg (which is more than 95 percentile for her age, gender and height).
BMI was recorded to be 20.2 kg/m 2 . Laboratory tests showed increased levels of plasma renin activity with normal levels of aldosteron. Blood urea nitrogen, creatinine and uric acid values were within normal limits.
Urinalysis reported elevated albumin/creatinin ratio and patient tested positive for proteinuria and microalbuminuria (24-hour urine collection). Renal ultrasounds was normal. The doppler of the renal arteries showed no significant differences in resistive index (RI on aa.arcuata left was 0.6 and RI on right aa. arcuata was 0.56). Evidence of retinopathia hypertensiva gradus I-II was discovered during fundus examination. There was no carotid, abdominal or femoral arterial bruits. The ECG was normal but echocardiography showed left ventricular hypertrophy.The suggested therapy for her hypertension was a calcium channel blocker.
A two-day study protocol was performed including a baseline scintigraphic study followed by another dynamic scintigraphy several days later, the latter with captopril premedication (25 mg of captopril) one hour before the test. The patient was hydrated with 10 ml of water per kg of body weight half an hour before both studies. BP was measured prior to the captopril intake and after 60 minutes of rest.
The study protocol for basal and captopril scintigraphy implies the patient being in the supine position with the gamma camera facing the lower back of the patient, with the kidneys, heart and bladder in the field of view. Starting immediately after the intravenous injection of 99mTc-MAG3 (Mallinckrodt Ltd.) at a dose according to an international scale, serial 10-second/frame images were obtained for 30 min. A single-headed large field of view gamma camera (Symbia, Siemmens) equipped with a general-purpose parallel-hole collimator was used. The analyses were made using the software for renal scintigraphy. 
Discussion
Arterial hypertension poses a significant risk factor for cardiovascular, renal and cerebrovascular diseases. In childhood, arterial hypertension is usually of secondary origin, mainly due to a renal disease. Since RVH is potentially treatable, it is essential to identify these patients.
As discussed above, conventional angiography is considered the gold standard in diagnosis but it is invasive, relatively expensive and exposes the kidney to a contrast load. with a normal renal function as presented in our case. (13) A number of studies, mainly referring to adult population, have shown different sensitivity and specificity of captopril scintigraphy in the detection of renovascular disease (14) . The research results in the adult population, as well as in the pediatric, were quite inconsistent.
The sensitivity and specificity of captopril scintigraphy greatly depended on the selected group of subjects. In the group of subjects with the preserved renal function, the sensitivity and specificity were approximately 90%, while in the group of patients with the impaired renal function tests showed a lower specificity. (11, 14, 15) In addition, some case studies point out the potential role of captopril scintigraphy in the evaluation of the effects of percutaneous transluminal dilatation of renal artery stenosis in hypertension (16) . In the presented case, captopril scintigraphy, performed immediately after the endovascular procedure, indicated significantly improved parenchymal indicators of the right kidney which corresponded to a complete normalization of patient's blood pressure occurring several months after the scintigraphy. This may indicate not only the importance of captopril scintigraphy in RVH screening but also its potential role in further monitoring of patients following endovascular procedures and its prognostic significance.
In conclusion, it could be said that captopril renal scintigraphy allows non-invasive functional testing in a selected group of hypertensive children, which can either confirm or rule out the existence of hemodynamically significant renal artery stenosis.
